US EditionPublished • loading... • Updated
Breathing Easier: A Minimally Invasive Option for Severe COPD/Emphysema
The one-way devices can improve breathing and reduce oxygen use, and more than 40,000 people worldwide have been treated, the company said.
- The Pulmonx Zephyr Endobronchial Valves offer a minimally invasive treatment for patients with severe emphysema, releasing trapped air and redirecting airflow to healthier lung tissue.
- New Jersey accountant Nick, 50, developed severe COPD after a long-term smoking habit and eventually became confined to his living room, tethered to an oxygen concentrator.
- Dr. Killol K. Patel, Director of Interventional Pulmonary at Hackensack Meridian Health Central Region, performed Nick's procedure; more than 40,000 people have been treated since FDA approval in 2018.
- Following his 2024 procedure, Nick lost more than 75 pounds, reduced several medications, and "I feel completely renewed," he said, now walking up to 15,000 steps daily.
- "When it comes to COPD care, what's most important is making sure patients are evaluated early," Patel said, emphasizing that awareness of treatment options significantly impacts patient quality of life.
Insights by Ground AI
138 Articles
138 Articles
Hastings Tribune+137 Reposted by 137 other sources
Breathing Easier: A Minimally Invasive Option for Severe COPD/Emphysema
(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple daily activities feel overwhelming. For people with severe COPD, walking across a room or climbing a flight of stairs can be exhausting. Today, however, new…
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources138
Leaning Left13Leaning Right10Center56Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
L 16%
C 71%
13%
Factuality
To view factuality data please Upgrade to Premium
